ScholarIQanswers from OpenAlex

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza

PaperCitations, authors & open-access status

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza have?

ScholarIQcitation count

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza has 69 citations in the OpenAlex counts ScholarIQ stores.

When was Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza published?

ScholarIQyear

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza has 2021 year in the ScholarIQ index.

What is the open-access status of Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza?

ScholarIQoa status

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza has gold oa status in the ScholarIQ index.

What is the DOI of Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza?

ScholarIQdoi

The DOI for Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza is on the source record.

What is the PMID of Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza?

ScholarIQpmid

The PMID for Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza is on the source record.

What is the OpenAlex record for Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza?

ScholarIQopenalex

The OpenAlex for Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial